What you'll learn

Manufacturing Injectables in the Multiplex describes a strategy to achieve flexibility and scale in biopharmaceutical manufacturing.

“The companies that are adopting the Multiplex strategy are beating traditional supply chains in terms of cost of goods, time to market and quality,” says Chris Procyshyn, CEO of Vanrx. “The pillars of the Multiplex are becoming a movement among the market leaders, so this is a must-read for executives looking to create a sustainable competitive advantage.”

Fill out my online form.